
|Articles|November 1, 2012
Nonablative fractional lasers afford results, minimize downtime
Laser resurfacing revolutionized the management of cutaneous photodamage ever since its introduction in the early 1980s. Initially, options were limited to fully ablative carbon dioxide (CO2) devices. Although results were impressive, the lengthy post-procedure downtime and substantial risks for infection, scarring and depigmentation drove the development of alternatives.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
2
Oruka Reports Positive Interim Phase 1 Data for ORKA-002, Advances ORKA-001
3
Alpha Tau Submits First PMA Module to FDA for Novel cSCC Treatment, Alpha DaRT
4
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
5


















